MYMX - Mymetics Corporation

Other OTC - Other OTC Delayed Price. Currency in USD

Mymetics Corporation

Biopole Center
Route de la Corniche, 4
Epalinges 1066
41 21 653 4535

Full Time Employees9

Key Executives

NameTitlePayExercisedYear Born
Mr. Ronald KempersCEO, Pres & CFO282kN/A1968
Dr. Sylvain FleuryChief Scientific Officer282kN/A1962
Mr. Anthony JessopSr. VPN/AN/A1941
Dr. Antonius Johannes StegmannHead of R&D and Chief Scientific Officer of Mymetics BVN/AN/AN/A
Mr. Mario Amacker Ph.D.Head of Quality & ManufacturingN/AN/AN/A
Amounts are as of December 31, 2018 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Mymetics Corporation, a vaccine company, focuses on research and developing vaccines for infectious diseases in Switzerland. The company's product pipeline includes vaccine candidates, such as HIV-1/AIDS, intra nasal influenza, malaria, and chikungunya.It has a collaboration agreement with Texas Biomedical Research Institute; PATH Malaria Vaccine Initiative; the Laboratory of Malaria Immunology and Vaccinology of the National Institute of Allergy and Infectious Diseases to develop and produce virosome based vaccine formulations for a malaria transmission-blocking vaccine candidate; RSV Corporation for developing the RSV vaccine; and Sanofi Pasteur Biologics, LLC to investigate the immunogenicity of influenza vaccines. The company was formerly known as ICHOR Corporation and changed its name to Mymetics Corporation in July 2001. Mymetics Corporation was founded in 1990 and is based in Epalinges, Switzerland.

Corporate Governance

Mymetics Corporation’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.